Clubhouse Media’s Influencer-Based Model and Las Vegas Content House Profiled in Top-25 Newspaper
Las Vegas Review-Journal Publishes Extended In-Depth Profile of Company’s Newest House and Overall Model and ProgressLOS ANGELES, April 13, 2021...
Day: April 13, 2021
Celularity Receives Orphan Drug Designation for Natural Killer Cell Therapy CYNK-001 in the Treatment of Malignant Gliomas
FLORHAM PARK, N.J., April 13, 2021 (GLOBE NEWSWIRE) -- Celularity Inc. (“Celularity”), a clinical-stage biotechnology company, leading the next evolution...
Acutus Medical Announces FDA Clearance of AcQCross™, a Full Suite of Universal Transseptal Crossing Devices
Product Family Targets Over 300,000 Annual US Electrophysiology and Structural Heart Procedures AcQCross Transseptal Crossing Device Versatility to be utilized...
Sensus Healthcare Announces the Sale/Install of its 500th Unit
Mid-Atlantic Skin Surgery Institute in Maryland acquires a second SRT systemBOCA RATON, FL, April 13, 2021 (GLOBE NEWSWIRE) -- Sensus...
Skylight Health Announces Fourth Quarter and Full Year Fiscal 2020 Earnings Conference Call
TORONTO, April 13, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc (TSXV:SHG; OTCQX: SHGFF) (“Skylight Health” or the “Company”), a...
electroCore Provides Business Update and Select First Quarter 2021 Financial Guidance
First-quarter 2021 revenue expected to be more than $1.1 millionNet cash used for the first quarter 2021 of approximately $4.1...
Inovalon Announces Inaugural Sustainability Report
Company Augments Annual Report with Assessment of Environmental, Social, and Governance (ESG) Elements of SustainabilityBOWIE, Md., April 13, 2021 (GLOBE...
Auris Medical Announces Positive Preclinical and Clinical Outcomes with AM-301 and Details Plans for Market Launch
Clinical evaluation of AM-301 nasal spray in allergic rhinitis meets primary endpoint Extended protection achieved over several hoursPreliminary preclinical data suggest...
BridgeBio Pharma and the University of California, San Diego Announce Collaboration to Advance Treatments for Genetically Driven Conditions
PALO ALTO, Calif., April 13, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ: BBIO), and the University of California, San...
Adagene Presents Preclinical Data from Lead SAFEbody™ Program, ADG126, at the American Association for Cancer Research (AACR) Annual Meeting 2021
SAN FRANCISCO and SUZHOU, China, April 13, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical...
BridgeBio Pharma, Inc. and UC Davis Establish Collaboration to Transform Research into Potential Therapies for Genetically Driven Diseases
PALO ALTO, Calif. and SACRAMENTO, Calif., April 13, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ: BBIO) today announced a...
BridgeBio Pharma, Inc. and Roswell Park Establish Collaboration to Translate Pioneering Research into Therapies for Genetically Driven Cancers
PALO ALTO, Calif. and BUFFALO, N.Y., April 13, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ: BBIO) today announced a...
BridgeBio Pharma, Inc. and Oregon Health & Science University Establish Collaboration to Translate Pioneering Research into Therapies for Genetically Driven Diseases
PALO ALTO, Calif., April 13, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ: BBIO) today announced a collaboration with Oregon...
BridgeBio Pharma, Inc. and The Lundquist Institute Collaborate to Advance Treatments for Genetically Driven Conditions and Cancers
TORRANCE, Calif. and PALO ALTO, Calif., April 13, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ: BBIO) and The Lundquist...
BridgeBio Pharma, Inc. and GlycoNet Initiate Collaboration to Discover Potential Treatments for Genetic Diseases through Glycomics Research
PALO ALTO, Calif. and EDMONTON, Alberta, April 13, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ: BBIO) and the Canadian...
vTv Therapeutics Receives FDA Breakthrough Therapy Designation for TTP399 for the Treatment of Type 1 Diabetes
Designation offers potential for expedited development pathway and reinforces TTP399’s potential to provide a substantial clinical benefitHIGH POINT, N.C., April...
PureK Holdings Corp. Announces Brand Partnership With Leading Cannabis/CBD Retailer Chemesis
PureKana Brand CBD Products to Become Available at Chemesis’ Proprietary ‘VICKI Intelligent Self-Checkout’ Kiosks Nationwide Chemesis International Inc. Chemesis VICKI...
VitalHub Announces the Appointment of New Board of Directors Member and Chairman of the Board
TORONTO, April 13, 2021 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce two...
Mydecine Announces Launch of Cutting-Edge Therapeutic Compound Screening
DENVER, April 13, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”),...
BridgeBio Pharma and Brown University Announce Partnership to Drive the Advancement of Academic Innovations in Genetically Driven Diseases into Potential Therapeutics for Patients
PALO ALTO, Calif. and PROVIDENCE, R.I., April 13, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ: BBIO), and Brown University...